Literature DB >> 28612021

Oligometastases of Gastrointestinal Cancer Origin.

Ernst Klar1, Markus W Büchler2, Hauke Lang3, Florian Lordick4, Jens Mittler3, Takashi Mizuno5, Guido Torzilli6, Alexis Ulrich2, Jean-Nicolas Vauthey5.   

Abstract

Entities:  

Year:  2017        PMID： 28612021      PMCID： PMC5465800          DOI： 10.1159/000463468

Source DB:  PubMed          Journal:  Visc Med        ISSN： 2297-4725


× No keyword cloud information.
  20 in total

1.  Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis.

Authors:  Mechteld C De Jong; Michael B Farnell; Guido Sclabas; Steven C Cunningham; John L Cameron; Jean-Francois Geschwind; Christopher L Wolfgang; Joseph M Herman; Barish H Edil; Michael A Choti; Richard D Schulick; David M Nagorney; Timothy M Pawlik
Journal:  Ann Surg       Date:  2010-07       Impact factor: 12.969

Review 2.  Summary outcomes of two-stage resection for advanced colorectal liver metastases.

Authors:  Terence C Chua; Winston Liauw; Francis Chu; David L Morris
Journal:  J Surg Oncol       Date:  2012-05-30       Impact factor: 3.454

3.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Murielle Mauer; Erik Tanis; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2013-10-11       Impact factor: 41.316

4.  Radical surgery of oligometastatic pancreatic cancer.

Authors:  T Hackert; W Niesen; U Hinz; C Tjaden; O Strobel; A Ulrich; C W Michalski; M W Büchler
Journal:  Eur J Surg Oncol       Date:  2016-11-09       Impact factor: 4.424

5.  Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary.

Authors:  G Mentha; P E Majno; A Andres; L Rubbia-Brandt; P Morel; A D Roth
Journal:  Br J Surg       Date:  2006-07       Impact factor: 6.939

Review 6.  Treatment of Neuroendocrine Liver Metastases.

Authors:  Heather A Farley; Rodney F Pommier
Journal:  Surg Oncol Clin N Am       Date:  2015-10-31       Impact factor: 3.495

Review 7.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

Authors:  René Adam; Aimery de Gramont; Joan Figueras; Norihiro Kokudo; Francis Kunstlinger; Evelyne Loyer; Graeme Poston; Philippe Rougier; Laura Rubbia-Brandt; Alberto Sobrero; Catherine Teh; Sabine Tejpar; Eric Van Cutsem; Jean-Nicolas Vauthey; Lars Påhlman
Journal:  Cancer Treat Rev       Date:  2015-06-30       Impact factor: 12.111

8.  Effect of specialist decision-making on treatment strategies for colorectal liver metastases.

Authors:  R P Jones; J-N Vauthey; R Adam; M Rees; D Berry; R Jackson; N Grimes; S W Fenwick; G J Poston; H Z Malik
Journal:  Br J Surg       Date:  2012-09       Impact factor: 6.939

9.  Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?

Authors:  S Crippa; A Bittoni; E Sebastiani; S Partelli; S Zanon; A Lanese; K Andrikou; F Muffatti; G Balzano; M Reni; S Cascinu; M Falconi
Journal:  Eur J Surg Oncol       Date:  2016-06-29       Impact factor: 4.424

10.  Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?

Authors:  Jessica E Maxwell; Scott K Sherman; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe
Journal:  Surgery       Date:  2015-10-09       Impact factor: 3.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.